These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22815789)

  • 1. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
    Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
    PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GITR agonist enhances vaccination responses in lung cancer.
    Zhu LX; Davoodi M; Srivastava MK; Kachroo P; Lee JM; St John M; Harris-White M; Huang M; Strieter RM; Dubinett S; Sharma S
    Oncoimmunology; 2015 Apr; 4(4):e992237. PubMed ID: 26137407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
    Lundqvist A; Yokoyama H; Smith A; Berg M; Childs R
    Blood; 2009 Jun; 113(24):6120-7. PubMed ID: 19202127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.
    Husain Z; Huang Y; Seth P; Sukhatme VP
    J Immunol; 2013 Aug; 191(3):1486-95. PubMed ID: 23817426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
    Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
    Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.
    Andersson A; Srivastava MK; Harris-White M; Huang M; Zhu L; Elashoff D; Strieter RM; Dubinett SM; Sharma S
    Clin Cancer Res; 2011 Jun; 17(11):3660-72. PubMed ID: 21636553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
    Porembka MR; Mitchem JB; Belt BA; Hsieh CS; Lee HM; Herndon J; Gillanders WE; Linehan DC; Goedegebuure P
    Cancer Immunol Immunother; 2012 Sep; 61(9):1373-85. PubMed ID: 22215137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
    Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
    Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H; Han Y; Guo Q; Zhang M; Cao X
    J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
    Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model.
    Xin M; Lin D; Yan N; Li H; Li J; Huang Z
    Anticancer Drugs; 2022 Feb; 33(2):117-123. PubMed ID: 34561996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.
    Alizadeh D; Trad M; Hanke NT; Larmonier CB; Janikashvili N; Bonnotte B; Katsanis E; Larmonier N
    Cancer Res; 2014 Jan; 74(1):104-18. PubMed ID: 24197130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.
    Chen L; He Z; Qin L; Li Q; Shi X; Zhao S; Chen L; Zhong N; Chen X
    PLoS One; 2011; 6(9):e24407. PubMed ID: 21931708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells.
    Wu T; Liu W; Guo W; Zhu X
    Biomed Pharmacother; 2016 Jul; 81():460-467. PubMed ID: 27261626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.
    Andersson A; Yang SC; Huang M; Zhu L; Kar UK; Batra RK; Elashoff D; Strieter RM; Dubinett SM; Sharma S
    J Immunol; 2009 Jun; 182(11):6951-8. PubMed ID: 19454692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.